ConvaTec, GB00BD3VFW73

ConvaTec stock fell 1.04 percent as buyback continued

Published on 09/28/2026 at 16:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

ConvaTec stock traded at GBp 209.40 on September 25, 2026, versus a 52-week high of GBp 259.20. Analysts set a GBp 305.44 average target.

Moderne Medizintechnik-Reinraumfertigung mit Technikern an steriler Produktionslinie
ConvaTec Group Plc GB00BD3VFW73 zeigt moderne Medizintechnik-Fertigung mit sterilen Produktionslinien und Reinraumtechnikern, Illustration mit AI erstellt.

ConvaTec stock (ISIN GB00BD3VFW73) fell 1.04 percent to GBp 209.40 in London trading on September 25, 2026, with the session range at GBp 209.20 to GBp 212.80. The latest capital-return update shows that ConvaTec bought back 4,406,581 shares between September 1 and September 4, according to Investegate on September 7, 2026.

Buyback adds a measurable signal

The repurchased shares were acquired at volume-weighted average prices between GBp 226.82 and GBp 230.98 and were placed in treasury. ConvaTec then held 114,702,844 shares in treasury, while 1,935,086,715 ordinary shares remained in issue, the company announcement said through Investegate.

That activity matters because the buyback prices were above the September 25 share price, while the treasury balance reduces the number of shares available for public ownership. The program therefore combines a direct capital-allocation action with a visible reference range for recent company purchases.

Analyst target remains above the market

According to MarketBeat on September 28, 2026, nine brokerages held a Moderate Buy consensus, with eight Buy ratings and one Hold rating. Their average one-year target was GBp 305.44, versus the GBp 209.40 closing price, while Berenberg cut its target from GBp 340.00 to GBp 335.00 and kept a Buy rating on September 11, 2026.

The target spread also shows the debate around valuation. Deutsche Bank and Royal Bank of Canada each cited GBp 315.00 targets, while Peel Hunt used GBp 270.00, according to MarketBeat.

Revenue grew in fiscal year 2025

Historical fiscal year 2025 revenue was GBP 2.439 billion, up from GBP 2.289 billion in fiscal year 2024, while net income declined to GBP 175.0 million from GBP 190.5 million, according to Reuters. The contrast between higher revenue and lower net income makes execution and margin delivery important alongside the buyback.

Stock stays below the yearly high

ConvaTec closed at GBp 209.40 on the London Stock Exchange on September 25, 2026, against a 52-week range of GBp 193.00 to GBp 259.20. MarketBeat placed the company's market capitalization at GBP 4.12 billion on September 28, 2026.

ConvaTec stock data

  • Company: ConvaTec Group Plc
  • ISIN: GB00BD3VFW73
  • Ticker: CTEC
  • Trading venue: London Stock Exchange
  • Price: GBp 209.40, closing price September 25, 2026
  • Market capitalization: GBP 4.12 billion as of September 28, 2026
  • 52-week range: GBp 193.00-259.20 as of September 25, 2026
  • Sector / Industry: Healthcare / Medical Instruments and Supplies

More news and analyses on ConvaTec stock

Disclaimer...

en | GB00BD3VFW73 | CONVATEC | boerse | 70193573 | bgmi